Regulators have authorized Takeda’s Qdenga vaccine for use in India, offering a new two-dose, tetravalent tool to combat the country's dengue challenges.

Despite incremental gains in infant immunization rates, the UN warns that geopolitical conflict, misinformation, and aid cuts threaten recent progress.